Clinical Trials Logo

Herpes Simplex, Genital clinical trials

View clinical trials related to Herpes Simplex, Genital.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04235322 Terminated - Clinical trials for Herpes Simplex, Genital

Study of 2LHERP® in Genital Herpes Infections

HEARTH-GEN
Start date: January 25, 2021
Phase: Phase 4
Study type: Interventional

Herpes simplex virus (HSV) infection is very common, as most people will experience herpetic infection during their lifetime. The most common manifestation of HSV infection is sores which may appear at any age. No specific antiviral therapy is available to totally cure herpetic infections and today, there is no treatment that allows the definitive eradication of the virus. The 2LHERP® has been available for more than 20 years, and has received a marketing authorization in Belgium by the FAMHP. It is used as an immune regulator in the treatment of herpetic infections. Since 2LHERP® has been made available, clinical observational data collected on treated patients have shown the beneficial effect on the disappearance of herpetic recurrences. The purpose of this placebo-controlled trial is to evaluate the efficacy of 2LHERP® on the treatment of herpetic infections in adults.